Amber Cai is a Venture Partner at F-Prime focusing on early-stage biotech. She founded Skyline Therapeutics and previously held leadership roles at Novartis in China and the US.
What Amber can write
F-Prime Capital writes $1M to $30M+ checks, larger than 83% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: F-Prime Capital.Career
- Novartis Institutes for BioMedical Researches · Business Development
- Novartis · Head of Operations
- Skyline Therapeutics · Founding CEO
- F-Prime · Venture PartnerNow
- Novartis’ R&D Center in China · Head of Operations2005-2006
- Skyline Therapeutics · CEO
Companies founded
Focus
Education
Also at F-Prime Capital
Partners like Amber
At firms with a similar stage, sector and check size.
Alert me when F-Prime Capital is active
One email when Amber's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Amber Cai?
Amber Cai is a Venture Partner at F-Prime focusing on early-stage biotech. She founded Skyline Therapeutics and previously held leadership roles at Novartis in China and the US.
How much does Amber Cai invest?
Amber Cai invests through F-Prime Capital, which writes checks of $1M to $30M+ at pre-seed, seed, series a, series b.
How do I pitch Amber Cai?
Email [email protected], the firm's inbox for founders, and name Amber in the subject. A warm intro from a founder F-Prime Capital backed works better.
What did Amber Cai do before F-Prime Capital?
Business Development at Novartis Institutes for BioMedical Researches; Head of Operations at Novartis; Founding CEO at Skyline Therapeutics; Head of Operations at Novartis’ R&D Center in China; CEO at Skyline Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.